Connect your AI

CalAmp CAMP Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Ionis PharmaceuticalsIONS

——

Rapport Therapeutics, Inc.RAPP

——

MeiraGTx Holdings plcMGTX

——

Taysha Gene Therapies, Inc.TSHA

——

CytomX TherapeuticsCTMX

——

Sarepta Therapeutics, Inc.SRPT

——

Other financials

Income statement

Revenue$1.3M+50.8%

Operating income-$13.1M+0.2%

Net income-$18.3M-47.4%

EPS (diluted)-$0.32+48.4%

Balance sheet

Cash & equivalents$100.8M+97.9%

Total debt$2.1M-73.2%

Total equity$30.9M-40.1%

Total assets$105.5M+68.0%

Cash flow

Operating cash flow-$11.0M+23.1%

CapEx--100%

Free cash flow-$11.0M+24.6%

Valuation

Market cap$226.92M+666%

Enterprise value$128.2M-3,860%

P/S57.7×+47.8×

Profitability

Operating margin-1,335.2%-512pp

Net margin-2,193.7%-581pp

FCF margin-1,254%—

Returns & leverage

Return on equity-209.3%—

Debt / equity0.1×-0.1×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CalAmp's software and technology licenses, net?: CalAmp (CAMP) reported software and technology licenses, net of $76K in Q1 2026.